Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 1,139 | 204 | 191 |
| Gross Profit | 1,139 | 204 | 191 |
| Operating Expenses | 115,805 | 55,653 | 35,437 |
| Operating Income | -114,666 | -55,449 | -35,246 |
| Other Income | 26,627 | 6,842 | -197 |
| Pre-tax Income | -88,039 | -48,607 | -35,443 |
| Net Income Continuous | -88,039 | -48,607 | -35,443 |
| Net Income | $-88,039 | $-48,607 | $-35,443 |
| EPS Basic Total Ops | -1.41 | -15.65 | -11.71 |
| EPS Basic Continuous Ops | -1.41 | -11.22 | -9.47 |
| EPS Diluted Total Ops | -1.41 | -15.65 | -11.71 |
| EPS Diluted Continuous Ops | -1.41 | -11.22 | -9.47 |
| EPS Diluted Before Non-Recurring Items | -1.41 | -15.65 | N/A |
| EBITDA(a) | $-119,626 | $-58,267 | $-35,187 |